RSVAX | VMVAX | RSVAX / VMVAX | |
Total Expense Ratio | 1.30 | 0.07 | 1,857% |
Annual Report Gross Expense Ratio | 1.33 | 0.07 | 1,900% |
Fund Existence | 32 years | 14 years | - |
Gain YTD | -1.565 | -0.023 | 6,907% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 255M | 29.9B | 1% |
Annual Yield % from dividends | 0.38 | 2.31 | 16% |
Returns for 1 year | -4.84 | 7.23 | -67% |
Returns for 3 years | 3.20 | 24.99 | 13% |
Returns for 5 years | 30.27 | 69.23 | 44% |
Returns for 10 years | -26.35 | 78.81 | -33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FUGAX | 45.29 | -0.29 | -0.64% |
Fidelity Advisor Utilities A | |||
LSAGX | 22.36 | -0.20 | -0.89% |
Loomis Sayles Global Growth A | |||
LIDAX | 9.41 | -0.13 | -1.36% |
Lord Abbett International Value A | |||
PRGTX | 21.38 | -0.36 | -1.66% |
T. Rowe Price Global Technology | |||
PEVAX | 15.13 | -0.30 | -1.94% |
PACE Small/Medium Co Value Equity A |